Data / Drug companies / Acyclovir
Acyclovir: 70 companies and 199 products in the FDA NDC directory
Acyclovir is listed in the FDA National Drug Code Directory by 70 companies, with 199 products in commercial distribution. 195 of the products (98.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; capsule; ointment, and the newest product started marketing on August 12, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 70
- Products
- 199
- Generic (ANDA) products
- 195 (98.0%)
- Application numbers
- 46
- Routes
- Oral, Topical, Intravenous, Ophthalmic, Cutaneous
- Brand names
- Zovirax, Avaclyr
- openFDA record search
- api.fda.gov
Companies that list acyclovir
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 17 | tablet; capsule | Generic drugs (ANDA) | June 20, 2023 |
| NuCare Pharmaceuticals,Inc. | 14 | tablet; capsule | Generic drugs (ANDA) | August 15, 2020 |
| A-S Medication Solutions | 13 | tablet; capsule | Generic drugs (ANDA) | June 20, 2023 |
| Remedyrepack Inc. | 10 | tablet; capsule | Generic drugs (ANDA) | August 19, 2025 |
| Proficient Rx LP | 9 | tablet; capsule | Generic drugs (ANDA) | May 4, 2018 |
| Bryant Ranch Prepack | 6 | capsule; tablet | Generic drugs (ANDA) | May 27, 2021 |
| Bryant Ranch Prepack | 5 | tablet; ointment | Generic drugs (ANDA) | January 30, 2020 |
| Preferred Pharmaceuticals Inc. | 5 | tablet; ointment | Generic drugs (ANDA) | August 12, 2026 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 4 | tablet; capsule | Generic drugs (ANDA) | March 25, 2026 |
| Proficient Rx LP | 4 | tablet | Generic drugs (ANDA) | September 10, 2014 |
| Zydus Lifesciences Limited | 4 | injection, solution; ointment | Generic drugs (ANDA) | March 3, 2023 |
| Zydus Pharmaceuticals USA Inc. | 4 | injection, solution; tablet | Generic drugs (ANDA) | November 27, 2018 |
| Apotex Corp. | 3 | tablet; capsule | Generic drugs (ANDA) | June 9, 2007 |
| Atlantic Biologicals Corp. | 3 | suspension | Generic drugs (ANDA) | March 9, 2023 |
| Aurobindo Pharma Limited | 3 | tablet; suspension | Generic drugs (ANDA) | September 11, 2025 |
| Cadila Pharmaceuticals Limited | 3 | tablet; capsule | Generic drugs (ANDA) | March 23, 2017 |
| Camber Pharmaceuticals, Inc. | 3 | tablet; suspension | Generic drugs (ANDA) | July 1, 2022 |
| Carlsbad Technology, Inc. | 3 | tablet; capsule | Generic drugs (ANDA) | August 17, 2017 |
| Chartwell RX, LLC | 3 | capsule; tablet | Generic drugs (ANDA) | March 12, 2021 |
| Golden State Medical Supply, Inc. | 3 | tablet; capsule | Generic drugs (ANDA) | August 16, 2017 |
| Modavar Pharmaceuticals LLC | 3 | tablet; capsule | Generic drugs (ANDA) | August 18, 2021 |
| Northwind Health Company, LLC | 3 | tablet; capsule | Generic drugs (ANDA) | June 27, 2023 |
| Proficient Rx LP | 3 | tablet; capsule | Generic drugs (ANDA) | June 20, 2023 |
| Viona Pharmaceuticals Inc | 3 | cream; capsule | Generic drugs (ANDA) | March 3, 2023 |
| Yiling Pharmaceutical, Inc. | 3 | tablet; capsule | Generic drugs (ANDA) | March 12, 2021 |
| Zydus Lifesciences Limited | 3 | tablet; capsule | Generic drugs (ANDA) | May 3, 2016 |
| Alembic Pharmaceuticals Inc. | 2 | cream; ointment | Generic drugs (ANDA) | March 27, 2025 |
| American Health Packaging | 2 | tablet | Generic drugs (ANDA) | June 6, 2025 |
| Amneal Pharmaceuticals LLC | 2 | ointment; cream | Generic drugs (ANDA) | November 11, 2020 |
| AvPAK | 2 | tablet | Generic drugs (ANDA) | July 18, 2014 |
| Bausch Health US LLC | 2 | ointment; cream | New drug applications (NDA) | December 30, 2002 |
| Bionpharma Inc. | 2 | tablet | Generic drugs (ANDA) | August 15, 2020 |
| Cardinal Health 107, LLC | 2 | capsule; tablet | Generic drugs (ANDA) | May 14, 2026 |
| Fresenius Kabi USA, LLC | 2 | injection, solution | Generic drugs (ANDA) | December 16, 2024 |
| Fresenius Kabi USA, LLC | 2 | injection, solution | Generic drugs (ANDA) | October 17, 2000 |
| Hikma Pharmaceuticals USA Inc. | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | February 29, 2016 |
| Major Pharmaceuticals | 2 | tablet; capsule | Generic drugs (ANDA) | October 24, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet; capsule | Generic drugs (ANDA) | June 20, 2023 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | November 29, 2013 |
| PharmPak, Inc. | 2 | tablet | Generic drugs (ANDA) | July 9, 2019 |
| Redpharm Drug | 2 | tablet | Generic drugs (ANDA) | June 20, 2023 |
| Square Pharmaceuticals Limited | 2 | tablet | Generic drugs (ANDA) | January 31, 2020 |
| Sun Pharmaceutical Industries, Inc. | 2 | cream; ointment | Generic drugs (ANDA) | June 13, 2024 |
| Westminster Pharmaceuticals, LLC | 2 | tablet | Generic drugs (ANDA) | June 20, 2023 |
| Actavis Pharma, Inc. | 1 | suspension | Generic drugs (ANDA) | September 3, 2002 |
| Advagen Pharma Ltd | 1 | suspension | Generic drugs (ANDA) | January 9, 2021 |
| Advanced Rx of Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | February 15, 2023 |
| Ani Pharmaceuticals, Inc. | 1 | suspension | Generic drugs (ANDA) | July 13, 2020 |
| Aryeh Pharma Corp | 1 | ointment | Generic drugs (ANDA) | April 10, 2026 |
| Asclemed USA, Inc. | 1 | tablet | Generic drugs (ANDA) | June 9, 2007 |
| Chartwell Governmental & Specialty RX, LLC. | 1 | suspension | Generic drugs (ANDA) | April 23, 2020 |
| Coupler LLC | 1 | tablet | Generic drugs (ANDA) | January 29, 2025 |
| Direct_Rx | 1 | tablet | Generic drugs (ANDA) | June 26, 2025 |
| Fera Pharmaceuticals, LLC | 1 | ointment | New drug applications (NDA) | January 31, 2026 |
| Florida Pharmaceutical Products, LLC | 1 | capsule | Generic drugs (ANDA) | February 18, 2026 |
| Glenmark Pharmaceuticals Inc., USA | 1 | ointment | Generic drugs (ANDA) | July 31, 2017 |
| Macleods Pharmaceuticals Limited | 1 | ointment | Generic drugs (ANDA) | August 13, 2018 |
| NorthStar Rx LLC | 1 | ointment | Generic drugs (ANDA) | July 31, 2017 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | April 29, 2026 |
| Novadoz Pharmaceuticals LLC | 1 | suspension | Generic drugs (ANDA) | March 9, 2023 |
| NuCare Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | September 10, 2014 |
| Padagis Israel Pharmaceuticals Ltd | 1 | cream | Generic drugs (ANDA) | February 11, 2019 |
| Quinn Pharmaceuticals | 1 | capsule | Generic drugs (ANDA) | May 27, 2021 |
| Slate Run Pharmaceuticals, LLC | 1 | injection, solution | Generic drugs (ANDA) | March 1, 2024 |
| Solco Healthcare US, LLC | 1 | ointment | Generic drugs (ANDA) | November 15, 2021 |
| Sportpharm LLC | 1 | ointment | Generic drugs (ANDA) | June 8, 2020 |
| St. Mary's Medical Park Pharmacy | 1 | tablet | Generic drugs (ANDA) | March 15, 2024 |
| Teva Pharmaceuticals USA, Inc. | 1 | cream | Authorized generics (NDA) | August 29, 2019 |
| Torrent Pharmaceuticals Limited | 1 | ointment | Generic drugs (ANDA) | January 11, 2019 |
| Xiromed, LLC | 1 | ointment | Generic drugs (ANDA) | January 30, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 112 | 56.3% |
| Capsule | 33 | 16.6% |
| Ointment | 23 | 11.6% |
| Suspension | 11 | 5.5% |
| Cream | 9 | 4.5% |
| Injection, solution | 9 | 4.5% |
| Injection, powder, lyophilized, for solution | 2 | 1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 195 | 98% |
| New drug applications (NDA) | 3 | 1.5% |
| Authorized generics (NDA) | 1 | 0.5% |
Pharmacologic classes
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.